InvestorsHub Logo
Followers 3
Posts 190
Boards Moderated 0
Alias Born 05/16/2013

Re: Nukemtiltheyglow post# 175545

Sunday, 02/10/2019 1:11:33 PM

Sunday, February 10, 2019 1:11:33 PM

Post# of 426728
Let’s put it this way: AMRN is GIA until BO. That’s why they have to hire and train sales staff, sign leases for office space etc. I can guarantee all here that a lease can be sub-leased, in case the space becomes unnecessary to AMRN or it’s successor. If anything the lease is yet another example of simply running a successful business...and the longer others take to consider a buyout the higher the potential cost of acquisition becomes.

HDG is once again right about BP not being able to let Vascepa and all those patents get away from them. (Thank you, JZ!) Just think, if EVAPORATE shows even modest results, V stands to become the number one prescription drug of all time. Even without EVAP it may still set Prescription records.

BP simply cannot afford to sit on the sidelines for this drug. In the meantime there are sales people to train and office leases that must go forward.

Hang in there folks! It’s coming, despite everything the opposition throws at it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News